摘要
目的观察富氢水、中成药(金复康口服液)或两者协同干预对胆管癌成瘤的影响。方法实验分为四组:对照组(n=10),富氢水组(n=10),金复康口服液组(n=5)和富氢水+金复康口服液组(n=5)。对照组予以成年SD雄性大鼠自由饮用含有硫代乙酰胺(300mg/L)水,实验组在饮用含硫代乙酰胺水的同时,分别经胃灌注适量富氢水、金复康口服液、富氢水+金复康口服液,20周处死所有大鼠,肉眼和显微镜下观察肝成瘤情况。结果9只可评价对照组大鼠在第20周时均形成肉眼以及镜下可见的肿瘤100%(9/9),而富氢水干预组7只大鼠可评价,肝肿瘤发生率为57.1%(4/7),金复康口服液干预组大鼠肝内肿瘤的成瘤率为40%(2/5),富氢水联合金复康口服液干预组大鼠肝内成瘤率为0(0/5)。结论富氢水+金复康口服液的协同作用能够成功阻断大鼠肝内胆管癌的发生。
Objective To observe the effect of hydrogen-rich water,traditional Chinese medicine(Jinfukang oral liquid,JFK)or their combined intervention on tumorigenesis of cholangiocarcinoma.Methods Adult male SD rats were divided into four groups in this study,including the control group(n=10),the hydrogen-rich water group(n=10),the JFK group(n=5)and the hydrogen-rich water+JFK group(n=5).Rats in control group were given free-drinking water containing thioacetamide(300 mg/L),while those in the experimental groups were given drinking water containing thioacetamide as well as hydrogen-rich water,JFK,or both.At 20 weeks after initiation,all rats were sacrificed,and the livers were carefully examined under the microscope.Results All ratable rats(n=9)(9/9)in the control group formed visible or microscopic tumors at 20 weeks,57.1%of rats(4/7)developed microscopic tumors in the hydrogen-rich water group,40%(2/5)developed microscopic tumors in the JFK group,while none of the rats(0/5)developed tumors in the hydrogen-rich water+JFK group.Conclusion The synergistic effect of hydrogen-enriched water and JFK can successfully block the occurrence of intrahepatic cholangiocarcinoma in rats.
作者
李超富
高云姝
周洲
魏培莲
徐家华
康志敏
孙学军
李和根
于观贞
LI Chaofu;GAO Yunshu;ZHOU Zhou;WEI Peilian;XU Jiahua;KANG Zhimin;SUN Xuejun;LI Hegen;YU Guanzhen(Department of Marine Medicine,Naval Medical University (SecondMilitary Medical University),Shanghai 200433,China;Department of Oncology,the Fourth Affiliated Hospital of Guangxi Medical University,Liuzhou 545005,Guangxi Province,China;Department of Oncology,the First Medical Center,Chinese PLA General Hospital,Beijing 100853,China;ShanghaiHuikang Hydrogen Medical Center,Shanghai 200433,China)
出处
《解放军医学院学报》
CAS
2019年第6期586-589,604,共5页
Academic Journal of Chinese PLA Medical School
基金
国家自然科学基金项目(81572856)
全军医药卫生科研基金(14ZD16)
上海中医药大学附属龙华医院高层次人才引进(LH02.51.002)~~
关键词
胆管癌
硫代乙酰胺
富氢水
金复康口服液
cholangiocarcinoma
thioacetamide
hydrogen-rich water
Jinfukang oral liquid